Search research articles
Contact Us
Filters
Showing results (161-170 of 199) with videos related to
Page
of 20
Sort By:
BMC Medical Informatics and Decision Making
|
February 22, 2017
The effect of a test ordering software intervention on the prescription of unnecessary laboratory tests - a randomized controlled trial
Carlos Manuel Silva Martins, Andreia Sofia da Costa Teixeira, Luís Filipe Ribeiro de Azevedo, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association
|
January 4, 2022
Adapting Elements of Cleft Care Protocols in Low- and Middle-income Countries During and After COVID-19: A Process-driven Review With Recommendations
Matthew Fell, Michael Goldwasser, B S Jayanth, et al.
The Lancet. Oncology
|
July 21, 2018
Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial
Michael Friedlander, Val Gebski, Emma Gibbs, et al.
Nature Communications
|
May 16, 2018
Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors
Manuel Rodrigues, Lenha Mobuchon, Alexandre Houy, et al.
Nature Communications
|
October 14, 2024
Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp
Manuel Rodrigues, Toulsie Ramtohul, Aurore Rampanou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 21, 2022
MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients
Mathilde Saint-Ghislain, Anne-Céline Derrien, Lionnel Geoffrois, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 22, 2021
Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy
Angelina Tjokrowidjaja, Michael Friedlander, Sarah J Lord, et al.
Gynecologic Oncology
|
August 15, 2022
Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohort
Quentin Dominique Thomas, Amal Boussere, Jean-Marc Classe, et al.
Current Oncology (Toronto, Ont.)
|
October 27, 2023
Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study
Fariba Nemati, Leanne de Koning, David Gentien, et al.
The Journal of Experimental Medicine
|
April 2, 2024
Divergent local and systemic antitumor response in primary uveal melanomas
Francesca Lucibello, Ana I Lalanne, Anne-Laure Le Gac, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 199) with videos related to
Sort By:
Page
of 20
BMC Medical Informatics and Decision Making
|
February 22, 2017
The effect of a test ordering software intervention on the prescription of unnecessary laboratory tests - a randomized controlled trial
Carlos Manuel Silva Martins, Andreia Sofia da Costa Teixeira, Luís Filipe Ribeiro de Azevedo, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association
|
January 4, 2022
Adapting Elements of Cleft Care Protocols in Low- and Middle-income Countries During and After COVID-19: A Process-driven Review With Recommendations
Matthew Fell, Michael Goldwasser, B S Jayanth, et al.
The Lancet. Oncology
|
July 21, 2018
Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial
Michael Friedlander, Val Gebski, Emma Gibbs, et al.
Nature Communications
|
May 16, 2018
Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors
Manuel Rodrigues, Lenha Mobuchon, Alexandre Houy, et al.
Nature Communications
|
October 14, 2024
Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp
Manuel Rodrigues, Toulsie Ramtohul, Aurore Rampanou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 21, 2022
MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients
Mathilde Saint-Ghislain, Anne-Céline Derrien, Lionnel Geoffrois, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 22, 2021
Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy
Angelina Tjokrowidjaja, Michael Friedlander, Sarah J Lord, et al.
Gynecologic Oncology
|
August 15, 2022
Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohort
Quentin Dominique Thomas, Amal Boussere, Jean-Marc Classe, et al.
Current Oncology (Toronto, Ont.)
|
October 27, 2023
Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study
Fariba Nemati, Leanne de Koning, David Gentien, et al.
The Journal of Experimental Medicine
|
April 2, 2024
Divergent local and systemic antitumor response in primary uveal melanomas
Francesca Lucibello, Ana I Lalanne, Anne-Laure Le Gac, et al.
Page
of 20